Berna Biotech to divest its veterinary business Gräub AG
10-Apr-2006
Berna decided to sell the fully owned Dr. E. Gräub, which employs 40 people, as production and sales of veterinary medicines are not among its core activities. This divestment is an important step towards aligning Berna's portfolio of activities with its strategic priorities.
The transaction will be formally concluded immediately upon approval by the competent competition authorities. Financial details were not disclosed.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.